EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

Description Of C-Reactive Protein (CRP) In Patients With Type 2 Diabetes Mellitus At Mulyorejo Health Center In Malang City

Febriyanti Wora Kapero, Erni Yohani Mahtuti, Previta Zeizar Rahmawati

Jurnal Analis Medika Biosains (JAMBS) · 2023

DOI: 10.32807/jambs.v10i2.320 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Jurnal Analis Medika Biosains (JAMBS), 2023. Verfasst von Febriyanti Wora Kapero und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes Mellitus Type 2 is a metabolic disorder condition characterized by hyperglycemia, due to decreased insulin secretion. Many cytokines play a role in the acute phase response, so that markers such as CRP increase in patients with type 2 DM. The type of research used in this study is descriptive research, which describes the results of CRP examination in patients with type 2 diabetes. Examination of respondents' serum C-Reactive Protein (CRP) levels was carried out qualitatively using the Latex Agglutination method and followed by a semi-quantitative method, namely dilution to determine the level of inflammation. The results of CRP examination on 30 serum samples that have been carried out on patients with Type 2 Diabetes Mellitus found that 29 (96.7%) were positive and 1 (3.3%) of respondents were negative. The group of CRP levels for titer 12 was 5 samples (16.7%), titer 24 was 17 samples (56.7%), titer 48 was 5 samples (16.7%), and titer 96 was 2 samples (6.7). %). The results of the four groups with the highest CRP levels, namely a titer of 24 mg/L as many as 17 samples (56.7%) showed that some of the CRP levels were higher than normal. Conclusion Almost all respondents with type 2 Diabetes Mellitus had positive C-Reactive Protein examination results and a small proportion of type 2 Diabetes Mellitus patients had negative C-Reactive Protein examination results.

Zitieren

APA

Kapero, F. W., Mahtuti, E. Y., & Rahmawati, P. Z. (2023). Description Of C-Reactive Protein (CRP) In Patients With Type 2 Diabetes Mellitus At Mulyorejo Health Center In Malang City. Jurnal Analis Medika Biosains (JAMBS). https://doi.org/10.32807/jambs.v10i2.320

Vancouver

Kapero FW, Mahtuti EY, Rahmawati PZ. Description Of C-Reactive Protein (CRP) In Patients With Type 2 Diabetes Mellitus At Mulyorejo Health Center In Malang City. Jurnal Analis Medika Biosains (JAMBS). 2023. doi:10.32807/jambs.v10i2.320

BibTeX
@article{Kapero2023,
  author = {Kapero, Febriyanti Wora and Mahtuti, Erni Yohani and Rahmawati, Previta Zeizar},
  title = {Description Of C-Reactive Protein (CRP) In Patients With Type 2 Diabetes Mellitus At Mulyorejo Health Center In Malang City},
  journal = {Jurnal Analis Medika Biosains (JAMBS)},
  year = {2023},
  doi = {10.32807/jambs.v10i2.320}
}
Kostenlos starten →